Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Publication year range
1.
Sci Justice ; 62(2): 229-238, 2022 03.
Article in English | MEDLINE | ID: mdl-35277237

ABSTRACT

Forensic soil comparisons can be of high evidential value in a forensic case, but become complex when multiple methods and factors are considered. Bayesian networks are well suited to support forensic practitioners in complex casework. This study discusses the structure of a Bayesian network, elaborates on the in- and output data and evaluates two examples, one using source level propositions and one using activity level propositions. These examples can be applied as a template to construct a case specific network and can be used to assess sensitivity of the target output to different factors and identify avenues for research.


Subject(s)
DNA Fingerprinting , Soil , Bayes Theorem , Humans , Likelihood Functions
2.
Br J Psychiatry ; 208(4): 366-73, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26892847

ABSTRACT

BACKGROUND: Mindfulness-based cognitive therapy (MBCT) and maintenance antidepressant medication (mADM) both reduce the risk of relapse in recurrent depression, but their combination has not been studied. AIMS: To investigate whether MBCT with discontinuation of mADM is non-inferior to MBCT+mADM. METHOD: A multicentre randomised controlled non-inferiority trial (ClinicalTrials.gov:NCT00928980). Adults with recurrent depression in remission, using mADM for 6 months or longer (n= 249), were randomly allocated to either discontinue (n= 128) or continue (n= 121) mADM after MBCT. The primary outcome was depressive relapse/recurrence within 15 months. A confidence interval approach with a margin of 25% was used to test non-inferiority. Key secondary outcomes were time to relapse/recurrence and depression severity. RESULTS: The difference in relapse/recurrence rates exceeded the non-inferiority margin and time to relapse/recurrence was significantly shorter after discontinuation of mADM. There were only minor differences in depression severity. CONCLUSIONS: Our findings suggest an increased risk of relapse/recurrence in patients withdrawing from mADM after MBCT.


Subject(s)
Antidepressive Agents/administration & dosage , Cognitive Behavioral Therapy , Depressive Disorder, Major/therapy , Mindfulness , Antidepressive Agents/therapeutic use , Combined Modality Therapy , Depressive Disorder, Major/drug therapy , Female , Humans , Male , Middle Aged , Recurrence , Secondary Prevention/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL